Abd Drugs Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.70 Cr
About Abd Drugs
Abd Drugs Private Limited (ADPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 May 2022 (Two years and nine months 15 days old ). Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.70 Cr.
Suneet Mohapatra and Srimanta Khatoi serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909OR2022PTC039620
-
Company No.
039620
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 May 2022
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Abd Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suneet Mohapatra
|
Director | 26-Apr-2024 | Current |
|
Srimanta Khatoi
|
Director | 03-Jan-2024 | Current |
Financial Performance of Abd Drugs.
Abd Drugs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abd Drugs?
Unlock access to Abd Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tanmantra Reality Private LimitedSuneet Mohapatra is a mutual person
-
Bd Medisys Private Limited
Suneet Mohapatra is a mutual person
-
Kds Agency Private Limited
Srimanta Khatoi is a mutual person
Charges (Loans)
₹17.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 1.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2024 | Bank Of India | ₹1.70 Cr | Open |
How Many Employees Work at Abd Drugs?
Abd Drugs has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abd Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abd Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
